2019 (2nd quarter of 2019) as follows: Q2/2018 Q1/2019 Q2/2019 QoQ % YoY % Net Revenue 251.20 194.28 221.13 26.85 13.82 -30.07 -11.97 Cost of Goods Sold 204.16 163.05 187.08 24.03 14.74 -17.08 -8.37

clarifies the changes in the performance over 20% as follows: FINANCIAL PERFORMANCE FOR 3 MONTHS AND 6 MONTHS ENDED 30 JUNE 2019 Consolidated Financial Statements Q2 2018 Q2 2019 Increase/(Decrease) 1H 2018

and its subsidiary for Quarter 2 of 2019 ending on 30 June 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for

mortgage and encumbrances i.e. building structure, machinery, materials equipment and non-used equipment, etc. of Tak Smelting Plant as follows; 1. Date of Transaction : Within August 2019 2. Related parties

follows: Financial Analysis Revenues The company had the total revenue as 198.96 million baht which is decreased as 62.62 million baht or 23.94% compared to the total income of previous year amounted of

Company”) would like to summarize its Q2/2019 operating performance for the period ending 30 June 2019 as follows: For the three-month, the Company and its subsidiaries’ posted a net loss of Baht 9.58

period ended 30 June 2019 which has been reviewed by the Auditor. The overall of the Company’s performance can be summarised as follows: Performance (Income Statement) Q2.2019 Q2.2018 Increase/(decrease

the six-month period ended 30 June 2019 which has been reviewed by the Auditor. The overall of the Company’s performance can be summarised as follows: Performance (Income Statement) Q2.2019 Q2.2018

has been audited by the auditor with significant operational results as follows. (Unit: Baht million) Consolidated* Quarter 2/2019 Quarter 2/2018 Increase / (Decrease) % Change Revenues from sales

Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the second quarter of 2019 at the end of 30th June 2019 as follows